Clinical Trial Update: Efficacy of Locally Delivred 1.2% Rosuvastatin Gel in Chronic Periodontitis [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 trial evaluated the efficacy of locally delivered 1.2% rosuvastatin gel for chronic periodontitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• Rosuvastatin Gel (1.2% local delivery) (rosuvastatin)

Snippet

Sponsor: Government Dental College and Research Institute, Bangalore | Conditions: Chronic Periodontitis | Phase 2, Phase 3 | Status: COMPLETED